| Name | 2,4,7,9-tetramethylbenzo[b][1,8]naphthyridin-5-amine |
|---|
| Description | BMH-22, a benzonaphthyridin, is a RNA polymerase I (Pol I) transcription inhibitor independent of p53 function. BMH-22 causes reorganization of nucleolar marker proteins consistent with segregation of the nucleolus. BMH-22 destabilizes RPA194 in a proteasome-dependent manner and inhibits nascent rRNA synthesis and expression of the 45S rRNA precursor. BMH-22 shows potent anticancer activity across many tumor types[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C16H17N3 |
|---|---|
| Molecular Weight | 251.32600 |
| Exact Mass | 251.14200 |
| PSA | 51.80000 |
| LogP | 4.18000 |
| HS Code | 2933990090 |
|---|
| HS Code | 2933990090 |
|---|---|
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |